Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
- de Graan, Anne-Joy M
- Lancaster, Cynthia S
- Obaidat, Amanda
- Hagenbuch, Bruno
- Elens, Laure
- Friberg, Lena E
- de Bruijn, Peter
- Hu, Shuiying
- Gibson, Alice A
- Bruun, Gitte H
- Corydon, Thomas J
- Mikkelsen, Torben S
- Walker, Aisha L
- Du, Guoqing
- Loos, Walter J
- van Schaik, Ron H N
- Baker, Sharyn D
- Mathijssen, Ron H J
- Sparreboom, Alex
Publication date
January 2012
DOI Publisher
American Association for Cancer Research (AACR)Abstract
The existence of at least two potentially redundant uptake transporters in the human liver with similar affinity for docetaxel supports the possibility that functional defects in both of these proteins may be required to confer substantially altered disposition phenotypes. In view of the established exposure-toxicity relationships for docetaxel, we suggest that caution is warranted if docetaxel has to be administered together with agents that potently inhibit both OATP1B1 and OATP1B3
Add to ORKG